These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

243 related items for PubMed ID: 28631642

  • 1. Sporadic occurrence of cryptococcal meningitis in HIV-seronegative patients: Uncommon etiology?
    Das S, Datt S, Roy P, Saha R, Xess I.
    Indian J Pathol Microbiol; 2017; 60(2):236-238. PubMed ID: 28631642
    [Abstract] [Full Text] [Related]

  • 2. Genotyping and antifungal susceptibility testing of Cryptococcus neoformans isolates from Cameroonian HIV-positive adult patients.
    Bertout S, Drakulovski P, Kouanfack C, Krasteva D, Ngouana T, Dunyach-Rémy C, Dongtsa J, Aghokeng A, Delaporte E, Koulla-Shiro S, Reynes J, Mallié M.
    Clin Microbiol Infect; 2013 Aug; 19(8):763-9. PubMed ID: 23033854
    [Abstract] [Full Text] [Related]

  • 3. In vitro antifungal activities of amphotericin B, 5-fluorocytosine, fluconazole and itraconazole against Cryptococcus neoformans isolated from cerebrospinal fluid and blood from patients in Serbia.
    Trpković A, Pekmezović M, Barać A, Crnčević Radović L, Arsić Arsenijević V.
    J Mycol Med; 2012 Sep; 22(3):243-8. PubMed ID: 23518082
    [Abstract] [Full Text] [Related]

  • 4. Antifungal susceptibilities of Cryptococcus neoformans cerebrospinal fluid isolates and clinical outcomes of cryptococcal meningitis in HIV-infected patients with/without fluconazole prophylaxis.
    Manosuthi W, Sungkanuparph S, Thongyen S, Chumpathat N, Eampokalap B, Thawornwan U, Foongladda S.
    J Med Assoc Thai; 2006 Jun; 89(6):795-802. PubMed ID: 16850679
    [Abstract] [Full Text] [Related]

  • 5. Cryptoccocal meningitis in Yaoundé (Cameroon) HIV infected patients: Diagnosis, frequency and Cryptococcus neoformans isolates susceptibility study to fluconazole.
    Kammalac Ngouana T, Dongtsa J, Kouanfack C, Tonfack C, Fomena S, Mallié M, Delaporte E, Boyom FF, Bertout S.
    J Mycol Med; 2015 Mar; 25(1):11-6. PubMed ID: 25467817
    [Abstract] [Full Text] [Related]

  • 6. Antifungal susceptibility of Cryptococcus neoformans to amphotericin B and fluconazole.
    Khyriem AB, Sujatha S, Parija SC.
    Indian J Pathol Microbiol; 2006 Apr; 49(2):307-8. PubMed ID: 16933750
    [Abstract] [Full Text] [Related]

  • 7. Increasing in vitro resistance to fluconazole in Cryptococcus neoformans Cambodian isolates: April 2000 to March 2002.
    Sar B, Monchy D, Vann M, Keo C, Sarthou JL, Buisson Y.
    J Antimicrob Chemother; 2004 Aug; 54(2):563-5. PubMed ID: 15254027
    [Abstract] [Full Text] [Related]

  • 8. A prospective descriptive study of cryptococcal meningitis in HIV uninfected patients in Vietnam - high prevalence of Cryptococcus neoformans var grubii in the absence of underlying disease.
    Chau TT, Mai NH, Phu NH, Nghia HD, Chuong LV, Sinh DX, Duong VA, Diep PT, Campbell JI, Baker S, Hien TT, Lalloo DG, Farrar JJ, Day JN.
    BMC Infect Dis; 2010 Jul 09; 10():199. PubMed ID: 20618932
    [Abstract] [Full Text] [Related]

  • 9. Invasive fungal infection by Cryptococcus neoformans var. grubii with bone marrow and meningeal involvement in a HIV-infected patient: a case report.
    Vechi HT, Theodoro RC, de Oliveira AL, Gomes RMODS, Soares RDA, Freire MG, Bay MB.
    BMC Infect Dis; 2019 Mar 04; 19(1):220. PubMed ID: 30832607
    [Abstract] [Full Text] [Related]

  • 10. The combination of tamoxifen with amphotericin B, but not with fluconazole, has synergistic activity against the majority of clinical isolates of Cryptococcus neoformans.
    Hai TP, Van AD, Ngan NTT, Nhat LTH, Lan NPH, Vinh Chau NV, Thwaites GE, Krysan D, Day JN.
    Mycoses; 2019 Sep 04; 62(9):818-825. PubMed ID: 31173410
    [Abstract] [Full Text] [Related]

  • 11. In vitro antifungal susceptibility profiles of Cryptococcus species isolated from HIV-associated cryptococcal meningitis patients in Zimbabwe.
    Nyazika TK, Herkert PF, Hagen F, Mateveke K, Robertson VJ, Meis JF.
    Diagn Microbiol Infect Dis; 2016 Nov 04; 86(3):289-292. PubMed ID: 27608538
    [Abstract] [Full Text] [Related]

  • 12. Comparison of clinical and biological characteristics of HIV-infected patients presenting Cryptococcus neoformans versus C. curvatus/C. laurentii meningitis.
    Zono B, Moutschen M, Situakibanza H, Sacheli R, Muendele G, Kabututu P, Biakabuswa A, Landu N, Mvumbi G, Hayette MP.
    BMC Infect Dis; 2021 Nov 15; 21(1):1157. PubMed ID: 34781895
    [Abstract] [Full Text] [Related]

  • 13. Cryptococcus neoformans and C. gattii isolates from both HIV-infected and uninfected patients: antifungal susceptibility and outcome of cryptococcal disease.
    Nascimento E, Vitali LH, Kress MRVZ, Martinez R.
    Rev Inst Med Trop Sao Paulo; 2017 Nov 15; 59():e49. PubMed ID: 28793019
    [Abstract] [Full Text] [Related]

  • 14. Antifungal drug susceptibility of Cryptococcus neoformans from clinical sources in Nairobi, Kenya.
    Bii CC, Makimura K, Abe S, Taguchi H, Mugasia OM, Revathi G, Wamae NC, Kamiya S.
    Mycoses; 2007 Jan 15; 50(1):25-30. PubMed ID: 17302744
    [Abstract] [Full Text] [Related]

  • 15. Liposomal amphotericin B (Fungisome) for the treatment of cryptococcal meningitis in HIV/AIDS patients in India: a multicentric, randomized controlled trial.
    Jadhav MP, Bamba A, Shinde VM, Gogtay N, Kshirsagar NA, Bichile LS, Mathai D, Sharma A, Varma S, Digumarathi R.
    J Postgrad Med; 2010 Jan 15; 56(2):71-5. PubMed ID: 20622383
    [Abstract] [Full Text] [Related]

  • 16. Cryptococcal meningitis in non-HIV patients in the State of Amazonas, Northern Brazil.
    Pinheiro SB, Sousa ES, Cortez ACA, da Silva Rocha DF, Menescal LSF, Chagas VS, Gómez ASP, Cruz KS, Santos LO, Alves MJ, Matsuura ABJ, Wanke B, Trilles L, Frickmann H, de Souza JVB.
    Braz J Microbiol; 2021 Mar 15; 52(1):279-288. PubMed ID: 33025379
    [Abstract] [Full Text] [Related]

  • 17. Susceptibility profile and epidemiological cut-off values of Cryptococcus neoformans species complex from Argentina.
    Córdoba S, Isla MG, Szusz W, Vivot W, Altamirano R, Davel G.
    Mycoses; 2016 Jun 15; 59(6):351-6. PubMed ID: 26865081
    [Abstract] [Full Text] [Related]

  • 18. Antifungal susceptibilities of Cryptococcus neoformans cerebrospinal fluid isolates from AIDS patients in Kenya.
    Mdodo R, Moser SA, Jaoko W, Baddley J, Pappas P, Kempf MC, Aban I, Odera S, Jolly P.
    Mycoses; 2011 Sep 15; 54(5):e438-42. PubMed ID: 21535451
    [Abstract] [Full Text] [Related]

  • 19. Timed-kill curves for Cryptococcus neoformans isolated from patients with AIDS.
    Rodero L, Córdoba S, Cahn P, Soria M, Lucarini M, Davel G, Kaufman S, Canteros C, Guelfand L.
    Med Mycol; 2000 Jun 15; 38(3):201-7. PubMed ID: 10892987
    [Abstract] [Full Text] [Related]

  • 20. [Cryptococcal meningitis].
    van Spil WE, Nooijen S, de Jong PY, Aliredjo RP, de Sévaux RG, Verhave JC.
    Ned Tijdschr Geneeskd; 2015 Jun 15; 159():A8478. PubMed ID: 25827149
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.